NCT00248495View on ClinicalTrials.gov

Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 8, 2005

Primary Completion Date

April 29, 2011

Study Completion Date

April 5, 2017

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

Given IV

DRUG

pemetrexed disodium

Given IV

PROCEDURE

adjuvant therapy

Metastasis prevention/control

PROCEDURE

conventional surgery

Undergoing tissue removal

PROCEDURE

neoadjuvant therapy

Tumor Reduction

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00248495 - Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter